InMed Pharmaceuticals

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

InMed Pharmaceuticals is a small biotechnology company based in Vancouver, British Columbia, focused on developing proprietary small molecule drug candidates that target the CB1 and CB2 receptors. Its pipeline includes three programs addressing Alzheimer's disease, ocular conditions, and dermatological indications. The company also operates BayMedica, its subsidiary, which is involved in the manufacturing, development, and commercialization of products based on rare cannabinoids and their proprietary small molecule drug analogs.

The firm operates in the biotechnology research sector, focusing on cannabinoid-based therapeutics for conditions with high unmet medical needs. Its activities are conducted through a blend of internal programs and its BayMedica subsidiary. A recent development is the appointment of John Bathery to its board of directors in October 2025.

Sign up for free to view info

Email Format Employee directory